GOV.UK
Membership
Membership and minutes for the Commission on Human Medicines and its expert advisory groups.
The Chair and Commissioners are appointed in accordance with the Code of Practice for Ministerial Appointments to Public Bodies, issued by the Commissioner for Public Appointments. The Chair and Commissioners follow a code of practice, in which they are precluded from holding personal interests. Their interests in the pharmaceutical industry are published in the Commission’s annual report each year.
The Commission meets monthly in London. The Commission is supported in its work by Expert Advisory Groups (EAGs), covering various areas of medicine. In addition, the Commission calls on experts not readily available through its membership.
Members and chair
Professor Stuart Ralston MB ChB MD FRCP FMedSci FRSE FFPM (Hon): Arthritis Research UK Professor of Rheumatology, University of Edinburgh, Western General Hospital, Edinburgh (Chair)
Dr J Colin Forfar BSc (Hons) MBChB PhD MD MA FRCP FRCP (Edin): Consultant Physician and Cardiologist, John Radcliffe Hospital, Oxford
Dr Jamie Fraser BSc MB ChB MRCGP GP Partner, Southside Surgery, Inverness
Professor Jonathan S Friedland MA PhD FRCP FRCPE FRCPI FMedSci: Hammersmith Campus Director and Head of Section of Infectious Diseases and Immunity, Imperial College London; Hon Consultant in Infectious Diseases ICHT
Dr Richard Gilson MD FRCP: Director, Centre for Sexual Health & HIV Research and Head, Research Department of Infection and Population Health, University College London
Professor Martin Gore CBE MBBS PhD FRCP: Medical Director and Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust and Professor of Cancer Medicine Institute of Cancer Research
Professor Malcolm R Macleod BSc MBChB MRCP PhD FRCP (Edin): Professor of Neurology and Translational Neurosciences, University of Edinburgh and Honorary Consultant Neurologist, NHS Forth Valley
Dr Rebecca Mann BM BS FRCPCH: Consultant Paediatrician, Taunton and Somerset NHS Foundation Trust
Dr Sarah Meredith: Deputy Director, MRC Clinical Trials Unit and Honorary Senior Lecturer, Department of Primary Care and Population Sciences, University College London
Dr Siraj Misbah MBBS (Hons) MSc FRCP FRCPath: Consultant Clinical Immunologist, Lead for Clinical Immunology, Oxford University Hospitals
Professor David G C Owens MD (Hons) FRCP FRCPsych Professor of Clinical Psychiatry, Edinburgh University
Professor Sir Munir Pirmohamed MB ChB (Hons) PhD FRCP FRCP (Edin) FMedSci David Weatherall Chair of Medicine, University of Liverpool, NHS Chair of Pharmacogenetics, Associate Executive Pro Vice Chancellor, Director of the Wolfson Centre for Personalised Medicine, Director of the MRC Centre for Drug Safety Science
Professor Shirley Price MSc PhD FBTS ERT FHEA FSB Head of Academic Appeals and Academic Quality and Professor of Toxicology, University of Surrey
Professor Kevin M G Taylor BPharm PhD MRPharmS Chair of the British Pharmacopoeia Commission and Professor of Clinical Pharmaceutics, UCL School of Pharmacy, London
Professor Angela E Thomas MB BS PhD FRCPE FRCPath FRCPCH (Vice Chair) Consultant Paediatric Haematologist, Royal Hospital for Sick Children, Edinburgh
Professor Helen M Ward MSc, BSc (Hons), RGN, RCN Nurse Practitioner, PGCEA, PG Cert NMP Associate Professor, Non-Medical Prescribing, London South Bank University
Professor Christopher Weir BSc (Hons) PhD MSc FRSS C.Stat C. Sci Personal Chair in Medical Statistics and Clinical Trials, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
Dr Martin Wilson MRCP (UK) MPhil (Glasgow), FRCP(Edin) Consultant Physician in Care of the Elderly, Raigmore Hospital, Inverness
Summary minutes
Summary minutes are prepared on the basis that no personal, commercial or otherwise confidential information is disclosed.
See the final summary minutes for CHM and EAGs from 2014 onwards, which you can download.
Yellow Card application form (MS Word Document, 142KB)
Previous minutes can be seen on the MHRA pages on the National Archives
Code of practice for chairmen and members of the commission on human medicines, certain committees and expert advisory groups (PDF, 103KB, 15 pages)
Meeting dates
2016
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 21/ 22 | 18/ 19 | 24 | 21/ 22 | 19/ 20 | 16 / 17 | 14/ 15 | 8/ 9 | 6/ 7 | 3/ 4 | 8/ 9 |
2017
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 19/20 | 16/17 | 16/17 | 13/14 | 11/12 | 15/16 | 13/14 | 7/8 | 5/6 | 2/3 | 7/8 |
2018
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 18/19 | 15/16 | 15/16 | 19/20 | 24/25 | 21/22 | 19/20 | 13/14 | 11/12 | 8/9 | 6/7 |
Infection EAG
Remit
To advise the Commission on the safety and efficacy of medicines for use in infections including HIV, AIDS and viral hepatitis.
Chair
Professor Jonathan S Friedland MA PhD FRCP FRCPE FRCPI FMedSci Hammersmith Campus Director & Head of Section of Infectious Diseases & Immunity, Imperial College London; Hon Consultant in Infectious Diseases ICHT
Members
Professor David Dockrell MB BCh MD FRCPI FRCP (Glas) FACP, Professor of Infection Medicine, University of Edinburgh
Dr Andrew Freedman B.A M.B,B.Chir M.A M.D FRCP FRCP Reader in Infectious Diseases, Cardiff University School of Medicine/ Hon. Consultant Physician, University Hospital of Wales
Dr Richard Gilson MD FRCP Director, Centre for Sexual Health & HIV Research and Head, Research Department of Infection and Population Health, University College London
Dr Richard Hobson MB BS MRCP (UK) FRCPath PhD Consultant Microbiologist and Honorary Senior Lecturer, Harrogate & District NHS Foundation Trust/University of Leeds
Dr Susan Hopkins MB ChB BAO (Hons) BA FRCPI Consultant in Infectious Diseases and Microbiology, Royal Free Hampstead NHS Trust, Healthcare Epidemiologist, Health Protection Agency, Honorary Senior Lecturer, University College London
Dr Katie Jeffery FRCP FRCPath Deputy Director of Infection Prevention and Control, Consultant Microbiologist (Clinical Lead), Oxford University Hospitals NHS Foundation Trust
Professor Martin Lombard MD MSc FRCP (Lond) Consultant Hepatologist & Gastroenterologist, Royal Liverpool University Hospitals NHS Trust
Dr Hermione Lyall BSc Hons MB ChB Hons MD FRCPCH Consultant in Paediatric Infectious Diseases, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London
Professor Kevin Moore BSc MB BS PhD FRCP Professor of Hepatology, Royal Free Hospital, London
Professor Robert C Read MBChB BMedSci MRCP MD FRCP Professor of Infectious Diseases and Head of Academic Unit, Clinical Experimental Science, University of Southampton
Dr Matthias Schmid MD FRCP DTMH Consultant Physician & Honorary Clinical Senior Lecturer, Head of Department of Infection & Tropical Medicine, Royal Victoria Infirmary
Ms Hilary A Shenton CPFA Lay Representative. Retired Secretary to the School of Medicine, University of Sheffield
Cardiovascular, Diabetes, Renal, Respiratory and Allergy EAG
Remit
To advise CHM on the safety and efficacy of medicines for used for the treatment and prevention of cardiovascular, diabetes, renal, respiratory and allergy diseases.
Chair
Dr J Colin Forfar BSc (Hons) MBChB PhD MD MA FRCP FRCP (Edin) Consultant Physician and Cardiologist, John Radcliffe Hospital, Oxford
Members
Dr Amanda Adler MD, PhD, FRCP Consultant Physician, Diabetes, Addenbrooke’s Hospital, Cambridge University Hospitals
Dr Iolo J Doull MRCP DM FRCPCH Consultant Respiratory Paediatrician, Respiratory/Cystic Fibrosis Unit, Children’s Hospital for Wales, Cardiff
Dr John Firth BA BM ChB DM FRCP Consultant Physician and Nephrologist, Addenbrooke’s Hospital, Cambridge
Dr Andrew Grace MB PhD FRCP FACC FESC Consultant Cardiologist, Papworth and Addenbrooke’s Hospitals Cambridge & Research Group Head, Department of Biochemistry, University of Cambridge
Professor Wasim Hanif MBBS MD FRCP Professor of Diabetes & Endocrinology, Consultant Physician and Clinical Director of Diabetes, University Hospital Birmingham
Dr Philip W Ind BA Cantab MB BChir MA Cantab FRCP Consultant Physician and Honorary Senior Lecturer in Respiratory Medicine, Imperial School of Medicine, Hammersmith Hospital
Dr Patrick Mark MB CHB (Hons) PhD FRCP Clinical Reader/Honorary Consultant Nephrologist University of Glasgow/Queen Elizabeth University Hospital, Glasgow
Professor Theresa McDonagh BSc (Hons), MB ChB (Hons), MD (Distinction), FRCP, FESC, FHFA Consultant Cardiologist, King’s College Hospital, London & Professor of Heart Failure King’s College, London
Professor Ann Millar MBChB MD FRCP (Vice Chair) Professor in Respiratory Medicine, Bristol University & Honorary Consultant, North Bristol NHS Trust
Dr Hilary Pinnock MB ChB (Hons) MRCGP MD Reader, Asthma UK Centre for Applied Research, Allergy and Respiratory Research Group, University of Edinburgh; General Practitioner, Whitstable Medical Practice
Dr Pallav L Shah MD MBBS FRCP Consultant Physician, Royal Brompton Hospital and Chelsea & Westminster Hospital, Reader in Respiratory Medicine, Imperial College
Dr Caroline Vaughan PhD Lay Representative of MHRA EAGS. Trustee and Director of Contact a Family and FamilyLine
Mr Phil Willan MSc Lay Representative. Member of Pharmacovigilance EAG; Member of the Royal College of Physicians’ (RCP) Patient and Carer Network; Member of the RCP Joint Speciality Committee (JSC) for Renal Medicine, Healthcare Associated Infections Working Group, Specialist Advisory Committee for Renal Medicine, JSC for Allergy and Immunology, Faculty of Forensic and Legal Medicine, Federation CPD Policy Committee and Equality and Diversity Monitoring Committee
Professor Sarah Wild MB BChir MSc PhD FRCPE FFPH, Professor of Epidemiology, Honorary Consultant in Public Health, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
Meeting dates
Chemistry, Pharmacy and Standards EAG
Remit
To advise the CHM on the quality in relation to safety and efficacy of medicinal products which are the subject of marketing authorisation applications and to advise on such other matters as are referred to it.
Chair
Professor Kevin M G Taylor BPharm PhD FRPharmS Chair of the British Pharmacopoeia Commission and Professor of Clinical Pharmaceutics, UCL School of Pharmacy, London
Members
Dr Majella Lane BSc PhD Senior Lecturer in Pharmaceutics, UCL School of Pharmacy
Professor Michael E Aulton BPharm PhD FRPharmS FAAPS FSP Emeritus Professor, De Montfort University, Leicester
Professor Graham Buckton BPharm PhD DSc FRPharmS FRSC Emeritus Professor of Pharmaceutics, UCL School of Pharmacy
Professor Derek Calam OBE MA DPhil Hon DSc CChem FRSC FRSA Hon MRPharmS Hon MTOPRA Visiting Professor of Pharmaceutical Sciences at the University of Strathclyde
Professor Brian J Clark MSc PhD CChem FRSC Professor of Pharmaceutical and Biomedical Analysis, Bradford University
Professor Ruth Duncan PhD Professor Emerita in Cell Biology and Drug Delivery, Cardiff University and Visiting Professor at the University of Greenwich
Mr V’Iain G Fenton-May BPharm MIPharm FRPharmS Pharmaceutical Microbiologist
Professor Geoffrey W Hanlon BSc PhD MRPharmS Emeritus Professor of Pharmaceutical Microbiology, School of Pharmacy & Bio-Molecular Sciences, University of Brighton
Dr Gillian M Hawksworth MBE PhD FFRPS FRPharmS (Hon) DSc Academic Community Pharmacist, Visiting Lecturer at University of Huddersfield & Past President of the RPSGB
Miss Carol E Knott MRPharmS MBA MIHM Lay Representative. Director of Windcliff Management Ltd
Mr Robert Lowe BPharmS MRPharmS Practising Hospital Pharmacist, NHS Eastern Region
Professor Christopher Marriott PhD DSc Hon DSc FRPharmS CChem FRSC FRSM (Vice Chair) Emeritus Professor of Pharmaceutics, King’s College, London
Professor Yvonne Perrie BSc Hons MRPharmS FAPS FSB PhD Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde.
Ms Hilary A Shenton CPFA Lay Representative. Retired Secretary to the School of Medicine, University of Sheffield
Professor Michael D Threadgill PGCE MA PhD DSc FRSC CChem Professor in Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath
Professor Peter York PhD BSc DSc FRPharmS CChem FRSC FAAPS Emeritus Professor of Pharmaceutics, Bradford University
Meeting dates
2016
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 | 16 | 22 | 19 | 17 | 14 | 12 | 6 | 4 | 1 | 6 |
2017
| Jan | Feb | March | April | May | June | July | Sept | Oct | Oct | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 | 14 | 14 | 11 | 9 | 13 | 11 | 5 | 3 | 31 | 5 |
2018
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 | 13 | 13 | 17 | 22 | 19 | 17 | 11 | 9 | 6 | 4 |
Clinical Trials, Biologicals and Vaccines EAG
Remit
To advise the CHM on:
- first time in human (FTIM) studies with new compounds acting (directly or indirectly) via the immune system with a novel target or a novel mechanism of action or having a secondary potential effect on the immune system via a mechanism of action which currently is not well characterised.
- FTIM studies with novel compounds acting via a possible or likely species specific mechanism
- Any FTIM studies which are otherwise seen as requiring expert advice
- Other clinical trials involving classes of compound where MHRA may wish to seek external expert advice or CHM may wish to have oversight
- Whether a product’s mechanism of action is novel and comes within the scope of the EAG
- Pre-meeting scientific advice documentation for within scope compounds
- Other clinical trials where MHRA may wish to seek advice or where there is a difficult risk benefit balance
- Other clinical trials involving products where a new class safety issue has been identified
- The quality, safety and efficacy of medicinal products of biological or biotechnological origin including vaccines which are the subject of marketing authorisation applications; and to advise on such other matters as are referred to it
Chair
Professor Angela E Thomas MB BS PhD FRCPE FRCPath FRCPCH Consultant Paediatric Haematologist, Royal Hospital for Sick Children, Edinburgh
Members
Professor Farzin Farzaneh DPhil FRCPath FRSB, Professor of Molecular Medicine, King’s College London, Honorary Consultant in Specialist Medicine, King’s College Hospital NHS Trust
Dr Elwyn Griffiths BSc PhD DSc CChem FRSC Consultant in Biologicals and Vaccines, World Health Organization; Formerly Director General, Biologics and Genetic Therapies Directorate, Health Canada, Ottawa, Canada
Dr Helen J Lachmann MD FRCP (Vice Chair) Reader and Honorary Consultant in Amyloidosis and Renal Medicine, University College London
Professor Elizabeth Miller OBE BSc MBBS FRCPath FFPHM FMedSci Consultant Epidemiologist, Immunisation Department, Centre for Infections, Health Protection Agency
Dr Siraj Misbah MBBS (Hons) MSc FRCP FRCPath Consultant Clinical Immunologist, Lead for Clinical Immunology, Oxford University Hospitals
Professor B Kevin Park BSc PhD FMedSci FRCP (Hon) FBTS Director of MRC Centre for Drug Safety Science, Professor of Pharmacology & Head of Institute of Translational Medicine, University of Liverpool
Professor Andrew Pollard PhD FRCPCH Chair of the Joint Committee on Vaccination and Immunisation; Professor of Paediatric Infection and Immunity, University of Oxford
Dr Peter F Searle BA PhD Senior Lecturer, School of Cancer Sciences, University of Birmingham
Dr Robin Thorpe PhD FRCPath Retired, Head, Division of Biotherapeutics, National Institute for Biological Standards and Control (NIBSC)
Professor Marc Turner MBBS PhD MBA FRCP FRCPath FHEA Professor of Cellular Therapy; Medical Director Scottish National Blood Transfusion Service (SNBTS)
Mrs Madeleine Wang BA (Hons) Lay Representative. Patient Advocate
Professor Christopher Weir BSc (Hons) PhD MSc FRSS C.Stat C. Sci Personal Chair in Medical Statistics and Clinical Trials, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
Meeting dates
2016
| Jan | Feb | March | April | May | June | July | Sept | Oct | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 | 15 | 21 | 18 | 16 | 13 | 11 | 5 | 3 | 31 | 28 |
2017
| Jan | Feb | March | April | May | June | July | Sept | Oct | Oct | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 | 13 | 13 | 10 | 8 | 12 | 10 | 4 | 2 | 30 | 4 |
2018
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 | 12 | 12 | 16 | 21 | 18 | 16 | 10 | 8 | 5 | 3 |
Gastroenterology, Rheumatology, Immunology and Dermatology EAG
Remit
To advise the CHM on the safety and efficacy of medicines for use in gastroenterological, rheumatological, immunological, and dermatological diseases.
Chair
Professor Anthony G Wilson MB BCH BAO DCH PhD FRCP Professor of Rheumatology, Medical School, University of Sheffield
Members
Dr Michael Ardern-Jones BSc MBBS DPhil FRCP Associate Professor, University of Southampton and Consultant Dermatologist
Dr Ian Barrison BSc MB FRCP FEBGH President European Board of Gastroenterology and Hepatology; Associate Dean, Postgraduate Medicine, School of Life and Medical Sciences, University of Hertfordshire
Mr David Chandler Lay Representative. Chief Executive, Psoriasis and Psoriatic Arthritis Alliance, Hertfordshire
Dr Richard Groves MB BS MRCP FRCP Consultant Dermatologist, St John’s Institute of Dermatology, Guy’s and St Thomas Hospital
Professor Kevin Moore BSc MB BS PhD FRCP Professor of Hepatology, Royal Free Hospital, London
Dr Frances Williams BSc MBBS MRCP PhD CCST FRCP (Edin) Reader in Genetic Epidemiology and Hon Consultant Rheumatologist, King’s College London
Meeting dates
Medicines for Women’s Health EAG
Remit
To advise the CHM on the safety and efficacy of medicines related to endocrinology and women’s reproductive health from menarche to menopause and conditions related to the menopause, such as osteoporosis. The medicines covered will include medicines for contraception, emergency contraception and termination of pregnancy; medicines for infertility and assisted conception; hormone replacement therapy (HRT) and non-hormonal treatments for osteoporosis.
Chair
Dr Ailsa Gebbie MB ChB FRCOG FRCPE FFSRH Consultant Gynaecologist and Deputy Director, Chalmers Centre, Edinburgh
Members
Professor Philip Hannaford MB ChB DRCOG DCH MD FRCGP FFSRH FFPH Professor of Epidemiology, University of Aberdeen
Professor Mary Lumsden OBE BSc MB BS MD FRCOG (Vice Chair) Professor of Medical Education & Gynaecology, University of Glasgow
Ms Linda Pepper BA MA (Education) Independent Consultant: patient and public involvement in healthcare
Professor Siobhan Quenby MBBS BSc MD FRCOG Professor of Obstetrics, Warwick University
Dr Clare Spencer MA MB BCHIR DM MRCOG MRCGP DFFPRHC GP Partner
Professor Jonathan H Tobias BA (Cantab) MBBS PhD (London) FRCP MD (London) Professor of Rheumatology, University of Bristol, and Honorary Consultant Rheumatologist, North Bristol Trust
Meeting dates
Neurology, Pain and Psychiatry EAG
Remit
To advise the CHM on the safety and efficacy of medicines for use in neurological conditions, pain management and psychiatric conditions.
Chair
Professor David G C Owens MD (Hons) FRCP FRCPsych Professor of Clinical Psychiatry, Edinburgh University
Members
Professor Thomas R. E. Barnes MD FRCPsych DSc Professor of Clinical Psychiatry, Imperial College London
Professor Naomi Fineberg BA Hons MB BS MA MRCPsych Consultant in General Adult Psychiatry, Hertfordshire Partnership NHS
Dr David Hunt MBMS MRCP PhD Honorary Consultant Neurologist/ Wellcome Trust Clinician Scientist, Anne Rawling Regenerative Neurology Clinic, University of Edinburgh
Dr Anthony L Johnson BSc PhD CStat Honorary Senior Research Associate, MRC Clinical Trials Unit at University College London
Professor Malcolm R Macleod BSc MBChB MRCP PhD FRCP (Edin) (Vice Chair) Professor of Neurology and Translational Neurosciences, University of Edinburgh and Honorary Consultant Neurologist, NHS Forth Valley
Professor John T O’Brien BA MA BMBCh DM FRCPsych Professor of Old Age Psychiatry, University of Cambridge
Dr Waqar Rashid MBBS BSc MRCP(UK) PhD Consultant and Honorary Clinical Senior Lecturer in Neurology, Brighton and Sussex University Hospitals NHS Trust, member of the Multiple Sclerosis Society
Dr Fergus Rugg-Gunn MB BS MRCP PhD Consultant Neurologist, National Hospital for Neurology and Neurosurgery, Queen Square, London
Dr Catherine F Stannard MB ChB FRCA FFPMRCA Consultant in Pain Medicine, Pain Clinic, Southmead Hospital, Bristol
Professor Christopher Weir BSc (Hons) PhD MSc FRSS C.Stat C. Sci Personal Chair in Medical Statistics and Clinical Trials, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
Meeting dates
Oncology and Haematology EAG
Remit
To advise the CHM on the safety, quality and efficacy of medicines used in the treatment of malignant disease or blood disorders.
Chair
Professor Martin Gore CBE MBBS PhD FRCP Medical Director and Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust and Professor of Cancer Medicine, Institute of Cancer Research
Members
Professor Stephen Devereux PhD FRCP FRCPath Consultant Haematologist, Kings College Hospital
Dr Hugo Ford MA MB BChir MD FRCP Director of Cancer Services, Cambridge University Hospitals
Dr Chris Gallagher BSc PhD FRCP Consultant Medical Oncologist, St Bartholomew’s Hospital, Barts and the London NHS Trust
Dr Geoff Shenton Consultant & Associate Clinical Lecturer in Paediatric and Adolescent Haematology & BMT, Great North Children’s Hospital, Newcastle upon Tyne
Professor Angela E Thomas MB BS PhD FRCPE FRCPath FRCPCH Consultant Paediatric Haematologist, Royal Hospital for Sick Children, Edinburgh
Invited expert
Professor A Hilary Calvert MB BChir MSc MD FRCP FMedSci Director of Cancer Drug Discovery and Development, UCL Cancer Institute
Meeting dates
2016
| April | May | June | July | Sept |
|---|---|---|---|---|
| 11 | 9 | 1 | 18 | 26 |
Paediatric Medicines EAG
The remit of the EAG is to advise the CHM on the safety, quality and efficacy of medicines for paediatric use, including all matters relating to the implementation of the EU Paediatric Regulation.
Chair
Dr Rebecca Mann BMBS FRCPCH Consultant Paediatrician, Taunton and Somerset NHS Foundation Trust
Members
Dr Eileen M Baildam MB ChB DRCOG DCH RCP FRCP FRCPCH Consultant Paediatric Rheumatologist and Honorary Senior Lecturer, Alder Hey Foundation NHS Trust and University of Liverpool
Dr Helen Burdett MB ChB MRCP FRCA Consultant Anaesthetist, Tunbridge Wells Hospital
Professor J Helen Cross MB ChB PhD FRCP FRCPCH, the Prince of Wales’s Chair of Childhood Epilepsy, Deputy Head of Developmental Neurosciences Programme, UCL Institute of Child Health
Professor Steven Cunningham MBChB PhD FRCPCH (Vice Chair) Consultant and Honorary Professor in Paediatric Respiratory Medicine, NHS Lothian Royal Hospital for Sick Children and University of Edinburgh
Professor Peter C Hindmarsh BSc MD FRCP FRCPCH Consultant Paediatric Endocrinologist, Royal Free and University College Medical School
Dr Meriel Jenney MBChB MRCP MD FRCPCH Consultant Paediatric Oncologist/Assistant Medical Director (Cancer Services), Children’s Hospital for Wales
Professor Nigel Klein BSc MBBS MRCP PhD FRCPCH Consultant, Great Ormond Street Hospital for Children NHS Trust; Professor of Infectious Diseases and Microbiology, Institute of Child Health, UCL
Dr Rubin Minhas MB ChB MBA GP Principal
Professor Marie-Louise Newell MB MSc PhD FMedSci Professor of Global Health, Academic Unit of Human Development and Health, Faculty of Medicine, University of Southampton
Professor Anthony Nunn BPharm FRPharmS Hon FRCPCH Honorary Fellow, Department of Women’s and Children’s Health, University of Liverpool; Industry Professor, School of Pharmacy and Biomedical Sciences, Liverpool John Moores University, Alder Hey Children’s Hospital, Liverpool
Ms Sara Payne BA CPE LPC Lay Representative. Solicitor
Dr Catherine L C Tuleu PhD Cert Ed MRPharmS Reader in the Department of Pharmaceutics, Director of the Centre for Paediatric Pharmacy Research, UCL School of Pharmacy
Professor Heather M Wallace PhD FRCPath FRSC FSB FBPharmacolS FBTS European Registered Toxicologist Professor of Biochemical Pharmacology and Toxicology, Division of Applied Medicine, University of Aberdeen
Mrs Madeleine Wang BA (Hons) Lay Representative. Patient Advocate
Dr Mark Whiting BNursing MSc PhD Consultant Nurse, Children’s Community and Specialist Nursing, Peace Children’s Centre, Hertfordshire Community NHS Trust
Dr Morris Zwi MB BCh FRCPsych Consultant Child & Adolescent Psychiatrist & Clinical Lead, Child & Adolescent Mental Health Services, Whittington Health, Clinical Lead for Islington Child & Adolescent Mental Health Services
Meeting dates
2016
| Jan | Feb | March | April | May | June | July | Aug | Sept | Sept | Oct | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 | 11 | 17 | 13 | 10 | 9 | 8 | 3 | 1 | 28 | 25 | 1 |
2017
| Jan | Feb | March | April | May | June | July | Aug | Sept | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 8 | 7 | 6 | 3 | 6 | 4 | 2/29 | 26 | 25 | 30 |
2018
| Jan | Feb | March | April | May | June | July | Aug | Sept | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 6 | 6 | 11 | 16 | 12 | 10 | 9 | 4 | 3/30 | 29 |
Patient and Public Engagement EAG
The remit of the EAG will be to advise the Commission on Human Medicines (CHM) on:
- the development of effective communications for patients, the public and carers to help them make informed choices about medicines and to use medicines safely
- how to improve communication between patients and health professionals and between the MHRA and the public on the safe use of medicines
- ways to promote the availability and accessibility of high quality information about individual medicines available in the UK
- ways to encourage reporting of adverse drug reactions (ADRs) by patients and the public - recognising the importance of the patient experience, to advise on building links between patient concerns as experienced in direct ADR reports and the information provided to patients
- facilitating targeted patient involvement on relevant regulatory issues, where patient/public involvement has not otherwise been achieved by working with specific patient organisations
- providing a patient perspective on strategic issues such as the upcoming European legislation on Patient Information
Chair Pro Tem
Mr Phil Willan MSc (Vice-Chair) Lay Representative. Member of the Royal College of Physicians (RCP) Patient and Carer Network; Member of the RCP Joint Speciality Committee (JSC) for Renal Medicine, Healthcare Associated Infections Working Group, Specialist Advisory Committee for Renal Medicine, JSC for Allergy and Immunology, Faculty of Forensic and Legal Medicine, Federation CPD Policy Committee and Equality and Diversity Monitoring Committee
Members
Ms Hellen Adom BA MA Lay Member. Outreach Assistant, NHS Sickle Cell & Thalassaemia Screening Programme, London
Mr David Chandler Lay Member. Chief Executive, Psoriasis and Psoriatic Arthritis Alliance, Hertfordshire
Mr John Chapman LL.B (Lon) Lay Member. Patient/Carer Member
Mrs Joyce Epstein Lay Member. Former Director of the Foundation for the Study of Infant Deaths (FSID)
Dr Nicola Jane Gray PhD MRPharmS FHEA FSAHM (US) Lay Member. Independent Pharmacist Researcher, Manchester
Ms Amanda Hoey Lay Member. Director, ConsumerHealth Consulting Ltd. Independent Health Policy and Strategy Consultant
Mrs Farrah Pradhan Lay Member. Invited Reviews Coordinator at the Royal College of Obstetricians and Gynaecologists
Mrs June Rogers MBE RN RSCN BA (Hons) MSc Lay Member. PromoCon Paediatric Advisor, Disabled Living
Dr Bella Starling PhD BSc Hons Dip Lay Member. Director of Public Programmes, Nowgen, a Centre for Genetics in Healthcare
Mr Paddy Storrie MA (Oxon) NPQH Lay Member. Deputy Headmaster, St. George’s School, Hertfordshire and Lay Member, N.I.C.E Technology Appraisals Committee
External experts
Mrs Anne Joshua BPharm (Hons) MSc Pharm Dip MRPharmS NHS 111 Pharmacy Lead, NHS England
Professor Angus Mackay OBE MA PhD (Cantab) MB ChB BSc (Pharmacol) FRCP (Edin) FRCPsych TPsych Professor of Psychological Medicine, University of Glasgow
Professor D K Theo Raynor BPharm (Hons) PhD MRPharmS Professor of Pharmacy Practice, University of Leeds
Pharmacovigilance EAG
PEAG now review applications for access to Type II Yellow Card data, the completed application form should be emailed directly to pharmacovigilanceservice@mhra.gov.uk
Yellow Card application form (MS Word Document, 142KB)
Remit
To advise the CHM on the following in relation to human medicines including herbal products:
- the public health importance of potential new signals
- the confirmation and quantification of risks identified
- appropriate risk minimisation measures including communications
- design and progress of pharmacovigilance plans
- methodologies for pharmacovigilance.
Chair
Professor Sir Munir Pirmohamed MB ChB (Hons) PhD FRCP FRCP (Edin) FMedSci David Weatherall Chair of Medicine, University of Liverpool, NHS Chair of Pharmacogenetics, Associate Executive Pro Vice Chancellor, Director of the Wolfson Centre for Personalised Medicine, Director of the MRC Centre for Drug Safety Science
Members
Professor Jamie Coleman MD MA (Med Ed) FRCP FBPhS Professor in Medical Education / Consultant Clinical Pharmacologist, University of Birmingham
Professor William Dixon MRCP PhD MRC Clinician Scientist and Honorary Consultant Rheumatologist, The University of Manchester
Dr Ian J Douglas BSc MSc PhD Senior Lecturer in Pharmacoepidemiology, London School of Hygiene & Tropical Medicine
Ms Amanda Lee RGN RM RNP MSc (NURS) BSc (Hons) Dip HEd PG Cert ANNP PhD student & Academic Lecturer Health Professional Studies, University of Hull
Professor Glyn Lewis BA MSc MB BS MRCPsych PhD Professor of Psychiatric Epidemiology, University College London
Professor Simon R J Maxwell MD PhD FRCP FRCPE FBPharmacolS FHEA Professor of Student Learning/Clinical Pharmacology, Western General Hospital, Edinburgh & University of Edinburgh
Dr Karen Miller BSc MBBS DRCOG DCH DFFP FRCGP GP Partner, Adelaide Medical Centre, London
Dr Nicholas J Plant BSc PhD Reader in Molecular Toxicology, University of Surrey
Ms Christine Randall BPharm MRPharmS, Assistant Director, North West Medicines Information Centre
Dr Ruben Thanacoody MD FRCP FRCP (Edin) Consultant Physician, Royal Victoria Infirmary; Honorary Clinical Senior Lecturer, Institute of Cellular Medicine, Newcastle University
Dr Caroline Vaughan PhD Lay Representative of MHRA EAGS. Governor of the Surrey and Sussex Healthcare NHS Trust
Mr Phil Willan MSc Lay Representative. Member of the Royal College of Physicians (RCP) Patient and Carer Network; Member of the RCP Joint Speciality Committee (JSC) for Renal Medicine, Healthcare Associated Infections Working Group, Specialist Advisory Committee for Renal Medicine, JSC for Allergy and Immunology, Faculty of Forensic and Legal Medicine, Federation CPD Policy Committee and Equality and Diversity Monitoring Committee.
Meeting dates
2016
| Jan | Feb | March | April | May | June | Aug | Sept | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|
| 6 | 3 | 9 | 6 | 4 | 1/29 | 24 | 21 | 19 | 23 |
2017
| Jan | Feb | March | April | May | June | Aug | Sept | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|
| 4 | 1 | 1/29 | 26 | 31 | 28 | 23 | 20 | 18 | 22 |
2018
| Jan | Feb | April | May | June | Aug | Sept | Oct | Nov |
|---|---|---|---|---|---|---|---|---|
| 3/31 | 28 | 4 | 9 | 6/27 | 29 | 26 | 24 | 21 |
Type II Yellow Card data
PEAG now review applications for access to Type II Yellow Card data, the completed application form should be emailed directly to pharmacovigilanceservice@mhra.gov.uk
Yellow Card application form (MS Word Document, 142KB)